Waters Corporation (WAT) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Waters Corporation (WAT) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

WAT

Market Closed

Waters Corporation

NYSEHealthcare Medical - Diagnostics & Research

7.60K employees

CEO: Udit Batra

Founded: 1995

$355.44

+$0.00(+NaN%)

Market Cap

23.17B

Beta

1.20

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

57.8%

4.0%

CAGR: 2.9%

Profit after direct costs

Operating Margin

28.2%

8.1%

CAGR: 2.1%

Core business profitability

Net Margin

20.3%

0.8%

CAGR: -1.9%

Bottom line profitability

Revenue Growth

7.0%

YoY

CAGR: 3.2%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how WAT allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

57.8%

$1.83B

Operating Margin

28.2%

$893.22M

Net Margin

20.3%

$642.63M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	2.79B	2.97B	2.96B	2.96B	3.17B	7.0%
Cost of Revenue	(1.16B)	(1.25B)	(1.20B)	(1.20B)	(1.34B)	11.4%
Gross Profit	1.63B	1.72B	1.76B	1.76B	1.83B	4.0%
Operating Expenses
Research & Development	(168.36M)	(176.19M)	(174.94M)	(183.03M)	(195.18M)	6.6%
Selling, General & Administrative	(626.97M)	(658.03M)	(736.01M)	(690.15M)	(740.27M)	7.3%
Depreciation & Amortization	(131.68M)	(130.42M)	(165.91M)	(191.82M)	(206.24M)	7.5%
Operating Income (EBIT)	821.71M	873.39M	817.68M	826.35M	893.22M	8.1%
Non-Operating Items
Interest Income	12.22M	11.02M	16.62M	17.42M	7.39M	-57.6%
Interest Expense	(44.94M)	(48.80M)	(98.86M)	(89.68M)	(69.55M)	-22.4%
Other Income/Expenses (Net)	-15.51M	-35.55M	-81.43M	-71.48M	-138.34M	93.5%
Income Before Tax	806.19M	837.85M	736.24M	754.87M	754.88M	0.0%
Income Tax Expense	(113.35M)	(130.09M)	(94.01M)	(117.03M)	(112.25M)	-4.1%
Net Income	692.84M	707.75M	642.23M	637.83M	642.63M	0.8%
Per Share Metrics
Earnings Per Share (Basic)	$11	$12	$11	$11	$11	0.5%
Weighted Avg Shares Outstanding	61.58M	59.98M	59.08M	59.33M	59.51M	0.3%
Weighted Avg Shares Outstanding (Diluted)	62.03M	60.33M	59.27M	59.55M	59.71M	0.3%
EBITDA	982.81M	1.02B	1.00B	1.04B	1.01B	-2.4%

Explore WAT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

WAT in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →